European Psychiatry - Volume 41 - April 2017

675 / 916

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S645–S709 S671
completed. Monthly net family income distributionwas: ≤150 euro
58 patients (27.1%); income between 150–500 euro 116 patients
(54.2%); ≥ 500 euro 40 patients (18.7%).
Results Patients with income ≤ 150 euro, compared to patients
with income ≥ 500 euro, had statistically significant worse global
health status (60.2 ±27.9 vs. 80.2 ± 19.2; P= 0.0007); worse phys-
ical functioning (80.3 vs. 69.1; P < 0.001); worse role functioning
(92.9 vs. 78.7; P = 0.009); worse sexual functioning (P = 0.019);
more severe fatigue (38 vs. 23; P= 0.01), nausea/vomitus (P = 0.041),
appetite loss (18.4 ± 7.5). Major depression was diagnosed in 35
patients. Depressed patients have less income than not depressed
patients (23.3% vs. 14.41%), but the difference did not reach statis-
tical significance.
Conclusions Lower income negatively affects many aspects of
quality of life. Specific interventions are needed for cancer sur-
vivors with lower socio-economic status to preserve and improve
the quality of life.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV0818
Mental disorders in patients breast
cancer: Differentiated approach to the
study Nozogeny
O. Shushpanova
Scientific Center of Mental Health, Department for the Study of
Children and Adolescent Psychiatry problems, Moscow, Russia
Objective The problem of mental disorders in patients with
breast cancer is relevant due to the high prevalence of pathological
changes in the mental health patients, insufficient development of
clinical typology of psychosomatic correlations of the contribution
of constitutional features.
Methods Nozogeny disorders are clinically heterogeneous and
are represented by two nosologic categories: reaction and noso-
genic patho-characterological personal development. The basic
method of work was a clinical follow-up and statistical research
methods (method using contingency tables and Fechner coefficient
method using the 2 – test).
Results The manifestation of a nozogeny reaction is closely
correlatedwith his premorbid personality characteristics. Anxious-
depressive nozogeny reaction was recorded in 17 patients of
the first sample with high direct correlation (coefficient Fech-
ner F = 0.76, P < 0.01) with respect to accentuation of personality
in the alarm type, and the weak direct link to the personal
characteristics of the affective (bipolar) range (F = 0.22, P < 0.01).
Anxious-nozogeny dissociative responsewas detected in 9 patients
with hysterical (55.5%) and expansive schizotypal (vershrobene)
(44.4%) lung cancer with a significant (F = 0.65, P< 0.01) a direct
correlation with constitutional hyperthymia, anxiety-hypomanic
nozogeny response was observed in patients c schizotypal RL
(n = 4) paired with symptoms of persistent hyperthymia (F = 0.39,
P = 0.012).
Conclusion Patho-characterological development of personality
are formed on the remote catamnestic stage breast cancer and show
the clinical heterogeneity of differentiation into 4 types: (1) the
type of hypochondriacal dysthymia, (2) the type of “paranoia strug-
gle”, (3) in an “aberrant hypochondria” and (4) the type of “new
life”.
Disclosure of interest The author has not supplied his/her decla-
ration of competing interest.
EV0819
Chemobrain and anxiety in a patient
with Hodgkin’s Lymphoma: Case
report and literature discussion
M. Silva ∗, M. Roque , P. Macedo , A. Fornelos
1 CHTMAD-E.P.E, Psychiatry department, Felgueiras, Portugal
2 CHTMAD-E.P.E, Psychiatry department, Vila Real, Portugal
∗ Corresponding author.
Impaired cognitive function is a common complaint among onco-
logic patients. Chemotherapy-induced cognitive impairment (CICI),
also called “chemobrain” or “chemofog” is currently recognized as
a relatively common adverse effect of chemotherapeutic agents
and is defined as the impairment of patients’ memory, learning,
concentration, reasoning, executive function, attention, and vis-
uospatial skills during and after discontinuation of chemotherapy.
In particular, it is apparent that a subset of chemotherapy-treated
haematological malignancy survivors experience cognitive impair-
ment. On the other hand, the emotional distress associated with
the disclosure of cancer diagnosis and/or the administration of
chemotherapy represents a strong reason for psychosomatic man-
ifestations in patients with cancer. The authors report a case of
a patient with Hodgkin’s lymphoma, cognitive impairment and
symptoms of anxiety and they propose to discuss the controversies
around the factors implicated on cognitive impairment in oncolo-
gical patients.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV0820
Carry on: Study of psychosocial needs
of oncological patients of the
Azores–Proposal for a support model
M. Sousa ∗ arreto Carvalho Moreira . Canavarro
1 University of Azores, Psychology, Ponta Delgada, Portugal
2 University of Azores, Cognitive and Behavioural Center for Research
and Intervention, CINEICC, Psychology, Ponta Delgada, Portugal
3 Cognitive and Behavioural Center for Research and
Intervention-CINEICC, Faculty of Psychology and Educational
Sciences, University of Coimbra, Psychology and Educational
Sciences, Coimbra, Portugal
∗ Corresponding author.
The number of new cases of cancer in Azores and the transfer of
oncological patients tomainland Portugal for specialized treatment
raise concerns about psychological adaptation and suitable support
care. Further studies regarding the lack of support interventions
available to meet the needs of Azorean oncological patients and
survivors are required. The main objectives of this study are: (1)
to evaluate psychosocial needs and other psychological adaptation
variables among adult oncological survivors from the Azores; and
(2), ensuing from objective (1), to develop a pilot study to test a
model of support with a group of oncological patients from the
Azores. Two studieswill be performed. The first dealswith objective
(1) as described. Based on results obtained, a randomized control
trial assessment will be run to test a support model based on the
patient advocacy movement with oncological patients. The assess-
ment protocol will be administrated three times: before and after
the model’s implementation and, again, as a follow-up. Results
should enhance knowledge of assessing psychological adaptation
variables involved in disease trajectory while testing a support
model addressing this study major concerns. These, as suggested,
relate to lack of support interventions to meet the psychosocial
needs of oncological patients and survivors from the Azores. Given
the peculiar experience of Azorean oncological patients’, while
away from their homes, there is a need to ensure adequate health
care services on their behalf. Hence, the importance of devising